Risk Factors Associated with Chemotherapy-Induced Nausea and Vomiting Among Women with Breast Cancer Receiving Highly Emetogenic Chemotherapy: Individual Patient-Based Analysis of... by Yeo W, Ngai NTY, Yip CCH, Mo FKF, Yeo VA, Ko JWH, Li LV, Lau TKH, Lai KT, Pang E, Yip CH, Yeo HL, Kwok CCH, Ko SWY, Molassiotis A

“…Winnie Yeo,1 Nicole TY Ngai,1 Christopher CH Yip,1 Frankie KF Mo,1 Victoria A Yeo,1 Jonathan WH Ko,1 Leung V Li,1 Thomas KH Lau,1 Kwai Tung Lai,1 Elizabeth Pang,1 Claudia HW Yip,1 Horatio L Yeo,1 Carol Chi Hei Kwok,2 Stephanie WY Ko,1 Alex Molassiotis3 1Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, SAR, People’s Republic of China; 2Department of Clinical Oncology, Princess Margaret Hospital, Kowloon, Hong Kong, People’s Republic of China; 3School of Nursing, The Hong Kong Polytechnic University, Hong KongCorrespondence: Winnie Yeo, Department of Clinical Oncology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, SAR, People’s Republic of China, Email winnieyeo@cuhk.edu.hkPurpose: Although risk factors related to chemotherapy-induced nausea and vomiting (CINV) have been identified in previous studies, only a few studies have evaluated the risk factors associated with contemporary antiemetic prophylaxis, including olanzapine/aprepitant- or NEPA-containing regimens. …”
Get full text

Significance of Immunogenic Cell Death-Related Prognostic Gene Signature in Cervical Cancer Prognosis and Anti-Tumor Immunity by Jiang S, Cui Z, Zheng J, Wu Q, Yu H, You Y, Zheng C, Sun Y

“…Shan Jiang,1,2 Zhaolei Cui,3 Jianfeng Zheng,1 Qiaoling Wu,1 Haijuan Yu,1 Yiqing You,3 Chaoqiang Zheng,3 Yang Sun1 1Department of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, People’s Republic of China; 2College of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, 350122, People’s Republic of China; 3Laboratory of Biochemistry and Molecular Biology Research, Department of Clinical Laboratory, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, People’s Republic of ChinaCorrespondence: Yang Sun, Department of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, Fujian, 350014, People’s Republic of China, Email sunyang@fjzlhospital.comBackground: Immunogenic cell death (ICD) can reshape the immune microenvironment of tumors. …”
Get full text

The Landscape of BRCA Mutations among Egyptian Women with Breast Cancer by Hamdy A. Azim, Samah A. Loutfy, Hatem A. Azim, Nermin S. Kamal, Nasra F. Abdel Fattah, Mostafa H. Elberry, Mohamed R. Abdelaziz, Marwa Abdelsalam, Madonna Aziz, Kyrillus S. Shohdy, Loay Kassem

Get full text

Assessment of clinical utility and predictive potential of pre-chemotherapy soluble urokinase plasminogen activator receptor: Observational single center study by Elina Beleva, Snezhana Stoencheva, Tanya Deneva, Ivanka Nenova, Zhanet Grudeva-Popova

Get full text

Immune Gene Signatures and Immunotypes in Immune Microenvironment Are Associated With Glioma Prognose by Xiang-Xu Wang, Haiyan Cao, Yulong Zhai, Shi-Zhou Deng, Min Chao, Yaqin Hu, Yaqin Hu, Yueyang Mou, Yueyang Mou, Shaochun Guo, Wenjian Zhao, Chen Li, Yang Jiao, Guolian Xue, Guolian Xue, Liying Han, Hong-Mei Zhang, Liang Wang

Get full text

Effect of the Renin-Angiotensin-Aldosterone System Reactivity on Endothelial Function and Modulative Role of Valsartan in Male Subjects with Essential Hypertension by Jakub Jasiczek, Małgorzata Trocha, Arkadiusz Derkacz, Ewa Szahidewicz-Krupska, Adrian Doroszko

Get full text

Improving Equity Across Cancer Care Continuum in Asia Pacific by Diah Martina, Eva Segelov

Get full text

The Family Practitioner’s role in the integrated continuum of cancer care by Martin de Villiers

Get full text

Reply to D. Vordermark and T. Pelz and R. Mazzola et al. by van Nimwegen, F, Cutter, D, Schaapveld, M, Darby, S, Aleman, B, van Leeuwen, F

Exosomes: A Source for New and Old Biomarkers in Cancer by Mariantonia Logozzi, Davide Mizzoni, Rossella Di Raimo, Stefano Fais

“…Clinical oncology needs reliable tumor biomarkers to allow a follow-up of tumor patients who do not necessarily need invasive approaches. …”
Get full text

DNA Ligase 4 Contributes to Cell Proliferation against DNA-PK Inhibition in <i>MYCN</i>-Amplified Neuroblastoma IMR32 Cells by Kiyohiro Ando, Yusuke Suenaga, Takehiko Kamijo

Get full text

Comparative analysis of outcome predictors in patients with postoperative peritonitis depending on the method of surgical treatment – relaparotomy on demand vs vacuum-assisted lapa... by I. B. Uvarov, D. D. Sichinava, A. M. Manuilov

Get full text

Rapid and automatic phenotyping of cells through their annexin-mediated enforced blebbing response by Wei Huang, Zheng Wang, Dennis WY Au, Bingxian Tang, Baiqian Qi, William C. Cho, Yuan Lin

Get full text

Vitiligo-like lesions induced by cyclin-dependent kinase 4/6 inhibitor Palbociclib: a case report and literature review by Shan Gao, Guanjing Wei, Yanrong Hao

Get full text

Does nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?: authors... by Zhen Gao, Shujie Huang, Sichao Wang, Dezhao Tang, Wei Xu, Ruijie Zeng, Guibin Qiao

Get full text

T065: Reproduction patterns among Classical Hodgkin Lymphoma Survivors Treated with BEACOPP and ABVD in Sweden, Denmark, and Norway by Joshua P. Entrop, Caroline E. Weibull, Karin E. Smedby, Lasse Hjort Jakobsen, Andreas K. øvlisen, Daniel Molin, Ingrid Glimelius, Anna Marklund, Harald Holte, Alexander Fosså, Knut B. Smeland, Tarec Christoffer El-Galaly, Sandra Eloranta

Get full text

Analysis of Social Science Research Into Cancer Care in Low- and Middle-Income Countries: Improving Global Cancer Control Through Greater Interdisciplinary Research by Banerjee, Dwaipayan, Mueller, Lucas

Get full text

Innovation to Advance Cancer Control Equitably by Tezer Kutluk, Sonali Johnson, Zuzanna Tittenbrun

Get full text

Are We Right on Target? Is Comprehensive Genomic Profiling Ready for Prime Time in Resource-Constrained Settings? by Joydeep Ghosh, Gilberto Lopes, Supriya Chopra

Get full text

Driving Equitable Access to Cancer Services Through the Engagement of People Living With Cancer: Regional Perspectives by Mélanie Samson, Maria Fatima Garcia-Lorenzo, Carol El Jabari

Get full text